PT - JOURNAL ARTICLE AU - HIRONOBU YANAGIE AU - MASASHI YANAGAWA AU - YASUYUKI MORISHITA AU - ATSUKO SHINOHARA AU - NOVRIANA DEWI AU - YASUMASA NONAKA AU - YOSHITAKA FURUYA AU - RYOUJI MIZUMACHI AU - YUUJI MURATA AU - HIROYUKI NAKAMURA AU - MINORU SUZUKI AU - YOSHINORI SAKURAI AU - HIROKI TANAKA AU - SHINICHIRO MASUNAGA AU - KOJI ONO AU - TAKUMICHI SUGIHARA AU - MASAYUKI NASHIMOTO AU - HARUO YAMAUCHI AU - MINORU ONO AU - JUN NAKAJIMA AU - HIROYUKI TAKAHASHI TI - Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems AID - 10.21873/invivo.12607 DP - 2021 Nov 01 TA - In Vivo PG - 3125--3135 VI - 35 IP - 6 4099 - http://iv.iiarjournals.org/content/35/6/3125.short 4100 - http://iv.iiarjournals.org/content/35/6/3125.full SO - In Vivo2021 Nov 01; 35 AB - Background/Aim: Tumor cell destruction by boron neutron capture therapy (BNCT) is attributed to the nuclear reaction between 10B and thermal neutrons. The accumulation of 10B atoms in tumor cells without affecting adjacent healthy cells is crucial for effective BNCT. We previously reported that several types of liposomal boron delivery systems (BDS) delivered effective numbers of boron atoms to cancer tissues, and showed tumor-growth suppression after thermal neutron irradiation. In the present study, we examined the effects of BNCT after intra-arterial infusion of 10B-borono-dodecaborate (10BSH) by liposomal BDS in rabbit hepatic cancer models. Materials and Methods: We prepared 10BSH-entrapped transferrin-conjugated polyethylene glycol liposomes constructed with distearoyl-boron lipid (TF-PEG-DSBL), and performed thermal neutron irradiation at the Kyoto University Institute for Integrated Radiation and Nuclear Science after intra-arterial infusion into rabbit VX-2 hepatic tumors. Results: Concentrations of 10B in VX-2 tumors on delivery with TF-PEG-DSBL liposomes reached 25 ppm on day 3 after the injection. Tumor growth was suppressed by thermal neutron irradiation after intra-arterial injection of this 10BSH-containing liposomal BDS, without damage to normal cells. Conclusion: The present results demonstrate the applicability of 10B-containing TF-PEG-DSBL liposomes as a novel intra-arterial boron carrier in BNCT for cancer.